Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
Open Access
- 22 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 163 (2) , 346-352
Abstract
Inflammation is an important biological process involved in many target organ toxicities. However, there has been little consensus on how to represent inflammatory processes using the adverse outcome pathway (AOP) framework. In particular, there were concerns that inflammation was not being represented in a way that it would be recognized as a highly connected, central node within the global AOP network. The consideration of salient features common to the inflammatory process across tissues was used as a basis to propose 3 hub key events (KEs) for use in AOP network development. Each event, “tissue resident cell activation”, “increased pro-inflammatory mediators”, and “leukocyte recruitment/activation,” is viewed as a hallmark of inflammation, independent of tissue, and can be independently measured. Using these proposed hub KEs, it was possible to link together a series of AOPs that previously had no shared KEs. Significant challenges remain with regard to accurate prediction of inflammation-related toxicological outcomes even if a broader and more connected network of inflammation-centered AOPs is developed. Nonetheless, the current proposal addresses one of the major hurdles associated with representation of inflammation in AOPs and may aid fit-for-purpose evaluations of other AOPs operating in a network context.Keywords
This publication has 19 references indexed in Scilit:
- Adverse outcome pathway networks I: Development and applicationsEnvironmental Toxicology and Chemistry, 2018
- Creating a Structured Adverse Outcome Pathway Knowledgebase via Ontology-Based AnnotationsApplied In Vitro Toxicology, 2017
- Adverse outcome pathways: opportunities, limitations and open questionsArchives of Toxicology, 2017
- Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision MakingThe Journal of Pharmacology and Experimental Therapeutics, 2016
- Adverse Outcome Pathway Development II: Best PracticesToxicological Sciences, 2014
- Adverse Outcome Pathway (AOP) Development I: Strategies and PrinciplesToxicological Sciences, 2014
- Alveolar macrophages: plasticity in a tissue-specific contextNature Reviews Immunology, 2014
- Tissue-resident macrophagesNature Immunology, 2013
- Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessmentEnvironmental Toxicology and Chemistry, 2009
- Inflammation and Drug Idiosyncrasy—Is There a Connection?The Journal of Pharmacology and Experimental Therapeutics, 2003